Orthofix Medical Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $453.0M | $433.8M | $409.8M | $396.5M | $402.3M | $397.6M | $440.2M | $435.5M |
| Cost of Revenue | $96.6M | $93.0M | $87.9M | $86.5M | $98.9M | $106.9M | $100.7M | $96.4M |
| Gross Profit | $356.4M | $340.8M | $321.9M | $310.0M | $303.4M | $290.7M | $339.5M | $339.1M |
| Gross Margin | 78.7% | 78.6% | 78.6% | 78.2% | 75.4% | 73.1% | 77.1% | 77.9% |
| Operating Expenses | ||||||||
| Research & Development | $33.2M | $29.7M | $28.8M | $26.4M | $25.0M | $26.8M | $28.6M | $22.9M |
| SG&A Expense | $83.3M | $71.9M | $76.4M | $87.2M | $79.1M | $67.5M | $53.7M | $64.8M |
| Operating Income | $30.1M | $40.8M | $21.1M | $9.3M | $17.1M | $-11.2M | $74.9M | $6.6M |
| Operating Margin | 6.6% | 9.4% | 5.1% | 2.3% | 4.3% | -2.8% | 17.0% | 1.5% |
| Interest Expense | — | — | — | — | $1.8M | $1.8M | $4.2M | $5.4M |
| Pretax Income | $22.9M | $36.4M | $19.0M | $8.5M | $12.5M | $-10.6M | $69.1M | $-1.4M |
| Income Tax Expense | $9.1M | $29.1M | $15.5M | $10.8M | $16.2M | $7.6M | $23.9M | $14.4M |
| Net Income | $13.8M | $6.2M | $3.1M | $-2.8M | $-8.5M | $-28.8M | $42.9M | $-17.7M |
| Net Margin | 3.0% | 1.4% | 0.7% | -0.7% | -2.1% | -7.2% | 9.7% | -4.1% |
| EPS (Basic) | $0.73 | $0.34 | $0.17 | $-0.15 | $-0.46 | $-1.54 | $2.26 | $-0.97 |
| EPS (Diluted) | $0.72 | $0.34 | $0.17 | $-0.15 | $-0.46 | $-1.54 | $2.21 | $-0.97 |
| Shares Outstanding (Basic) | 18.5M | 18.1M | 18.1M | 18.8M | 18.5M | 18.7M | 19.0M | 18.2M |
| Shares Outstanding (Diluted) | 18.9M | 18.5M | 18.5M | 18.8M | 18.5M | 18.7M | 19.4M | 18.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |